Successful Tarlatamab Rechallenge After Recurrent High-Grade Cytokine Release Syndrome in Chromothripsis-Mediated SCLC: A Case Report

Chromothripsis-mediated SCLC (cSCLC) is a distinct subtype of SCLC characterized by wild-type TP53 and RB1, arising in light- or never-smokers. Although data are limited, cSCLC may be associated with poor response to first-line platinum-based chemotherapy. We report the case of a 60-year-old woman w...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ryan Cheng, MD, Sarah Reddy, MD, Kendra Gee-Rodriguez, PharmD, Rogelyn Harlan, MS, FNP-C, Chetan Vakkalagadda, MD, Jeremy Cetnar, MD, Rebecca Silbermann, MD, Richard T. Maziarz, MD, Rajat Thawani, MD
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2026-06-01
סדרה:	JTO Clinical and Research Reports
נושאים:	Tarlatamab Cytokine release syndrome Lung cancer in non-smokers Case report
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2666364326000482
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!